Tonix Pharmaceuticals Holding Corp. (TNXP)
$6.13-7.68%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $98M
- Beta
- 1.79
- P/E (TTM)
- -0.46
- Short % float
- 18.49%
- Days to cover
- 5.9
- SI change
- +3.5%
- 1W
- -20.39%
- 1M
- -47.74%
- vs SPY 1W
- -20.25%
- vs SPY 1M
- -50.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 19
- VALUE
- 32
- GROWTH
- 43
- GARP
- 8
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-41.4%
REV YoY-
ROE-69.0%
EPS YoY-
ROA-62.8%
GROSS80
OP-568
NET-549
[VALUATION]
P/E TTM-0.46
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B0.46
P/FCF-
EV/EBITDA0.49
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.57
ALTMAN Z-
CURR RATIO6.61
ND/EBITDA-
BETA1.79
Company news
FAQ
- What is LOPJLB’s current signal on TNXP?
- LOPJLB’s latest quantitative signal on Tonix Pharmaceuticals Holding Corp. (TNXP) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TNXP in?
- Tonix Pharmaceuticals Holding Corp. (TNXP) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Tonix Pharmaceuticals Holding Corp. (TNXP) do?
- Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treat…